Literature DB >> 11719123

Incidence and risk of potential adverse drug interactions in the emergency room.

D Heininger-Rothbucher1, S Bischinger, H Ulmer, C Pechlaner, G Speer, C J Wiedermann.   

Abstract

OBJECTIVE: To determine the incidence and risk factors of potential adverse drug interactions occurring in patients in the emergency department.
DESIGN: Survey of a random sample of medical records of elderly persons and other adults seeking care at an emergency department. The interactions were determined by a computer programme, reviewed using explicit criteria, and excluded if of uncertain or trivial clinical significance.
SETTING: University Hospital Medical Emergency Department. PATIENTS: A total of 423 randomly selected adults seeking care at a university hospital emergency department. Attendances made by 195 persons over age 60 and 228 younger adults were evaluated. All subjects were treated on an outpatient basis. MAIN OUTCOME MEASURES: Seventy percent of attendances led to the prescription of an added medication. In 5.4% of the attendances in which at least one medication was added, the new medication introduced a potential adverse interaction. The number of medications used at attendance was the best predictor of whether a potential interaction would occur. Additional medications prescribed in the emergency department that accounted for most of the added interactions were theophylline, macrolid antibiotics, digitalis glycosides, nonsteroidal anti-inflammatory agents, angiotensin converting-enzyme inhibitors and calcium antagonists.
CONCLUSIONS: Potential adverse drug interactions were more common in elderly patients because of the higher number of concurrent medications rather than age-based factors. Safeguards need to be introduced to prevent patients from receiving medications in the emergency departments that have the potential to cause adverse interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719123     DOI: 10.1016/s0300-9572(00)00363-4

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  15 in total

1.  Frequency and nature of drug-drug interactions in a Dutch university hospital.

Authors:  Jeannette E F Zwart-van Rijkom; Esther V Uijtendaal; Maarten J ten Berg; Wouter W van Solinge; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

2.  A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital.

Authors:  Vijay Kulkarni; Swathi Swaroopa Bora; Sapineni Sirisha; Mohammed Saji; Siraj Sundaran
Journal:  Ther Adv Drug Saf       Date:  2013-08

3.  Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.

Authors:  Cristiano Moura; Nília Prado; Francisco Acurcio
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

4.  Evaluation of community pharmacists' knowledge and awareness of food-drug interactions in Palestine.

Authors:  Asma Radwan; Anwar Sweileh; We'am Shraim; Amr Hroub; Josephean Elaraj; Naser Shraim
Journal:  Int J Clin Pharm       Date:  2018-05-02

Review 5.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11

6.  Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

Authors:  Linda R Tulner; Suzanne V Frankfort; George J P T Gijsen; Jos P C M van Campen; Cornelis H W Koks; Jos H Beijnen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.

Authors:  Agnes L F Chan; Meng-Ting Wang; Chen-Yi Su; Fu-Hsiung Tsai
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

8.  Potential drug-drug interactions in the medication of medical patients at hospital discharge.

Authors:  Sabin S Egger; Jürgen Drewe; Raymond G Schlienger
Journal:  Eur J Clin Pharmacol       Date:  2003-02-21       Impact factor: 2.953

9.  Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases.

Authors:  Omalhassan Amir; Yahaya Hassan; Azmi Sarriff; Ahmed Awaisu; Noorizan Abd Aziz; Omar Ismail
Journal:  Pharm World Sci       Date:  2009-03-03

10.  Prevalence of potential drug interactions in an Iranian general hospital.

Authors:  G Sepehri; P Khazaelli; F Arabpour Dahooie; E Sepehri; M R Dehghani
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.